FDA-drug screening identifies deptropine inhibiting hepatitis E virus involving the NF-κB-RIPK1-caspase axis
Titel:
FDA-drug screening identifies deptropine inhibiting hepatitis E virus involving the NF-κB-RIPK1-caspase axis
Auteur:
Qu, Changbo Li, Yang Li, Yunlong Yu, Peifa Li, Pengfei Donkers, Joanne M. van de Graaf, Stan F.J. de Man, Robert A. Peppelenbosch, Maikel P. Pan, Qiuwei